Pharmaceutical

Pharmaceutical Processing reports that, according to a new report from GlobalData, Taiwan’s pharmaceutical market will grow from $5.4 billion in 2013 to $8.4 billion by 2020. This expansion is expected to occur despite the ongoing tensions with China which could potentially hinder Taiwan’s economic growth.

Pharmaceutical Processing reports that, according to a new report from GlobalData, Taiwan’s pharmaceutical market will grow from $5.4 billion in 2013 to $8.4 billion by 2020. This expansion is expected to occur despite the ongoing tensions with China which could potentially hinder Taiwan’s economic growth.
According to the article:
The company’s latest report states that diplomatic isolation, high out-of-pocket expenditure and the inefficient distribution of healthcare facilities are the foremost challenges to Taiwan’s pharmaceutical sector.
[…] Despite these reservations, Taiwan’s pharmaceutical outlook remains positive, with opportunities presented by a free trade agreement with the US, low-taxation investment environment, harmonized clinical trial process, an efficient patent system, and strong incentives for Research and Development (R&D).
Click here to read the full article on Pharmaceutical Processing.
 
 

MARKETS

Markets
TSX18861.36-217.28
TSXV617.26-9.08
DOW31097.26+321.83
S&P 5003825.33+39.95
NASD11127.85+99.11
ASX6539.90-28.20

COMMODITIES

Commodities
Gold1809.91-0.13
Silver19.89+0.03
Copper3.61-0.10
Palladium1965.07+9.98
Platinum891.26+2.98
Oil108.46+2.70
Heating Oil3.96+0.13
Natural Gas5.620.00

DOWNLOAD FREE REPORTS

×